Results 101 to 110 of about 509,494 (205)

Editorial: Biomarkers and precision medicine in myeloid neoplasms. [PDF]

Front Cell Dev Biol
Datta Mitra A.
europepmc   +1 more source

High-dimensional spectral flow cytometry uncovers progressive T-cell exhaustion and myeloid cell reprogramming in a CLL mouse model. [PDF]

Hemasphere
Briesch H, Coelho M, Floerchinger A, Borysovych Y, Aubert N, Medina-Gil D, Breitinger M, Zapatka M, Autenrieth SE, Seiffert M.   +9 more
europepmc   +1 more source

Chronic myeloid leukemia

HemaSphere, 2019
openaire   +3 more sources

Acute myeloid leukemia with unusual mature lymphoid-like morphology in a subset of blasts. [PDF]

J Hematop
Vossen C, E Jordan C.
europepmc   +1 more source

Venetoclax with azacitidine and dexamethasone: Non-cytotoxic induction therapy for T-cell leukemia and mixed-phenotype leukemia. [PDF]

Ther Adv Hematol
Lei Y, Zhao X, Huang H, Duan L, Xu J, Miao K, Zhao H, Qiao C, Hong M, Qian S, Fan L, Zhu Y.   +11 more
europepmc   +1 more source

Identification of ultrasound-associated gene candidates in myeloid cells and construction of a prognostic risk model for acute myeloid leukemia. [PDF]

PeerJ
Zhu L, Dai Y.
europepmc   +1 more source

Acute myeloid leukemia

HemaSphere, 2019
openaire   +3 more sources

A Case of Acute Myeloid Leukemia, Myelodysplasia-Related (AML-MR) with Immunophenotypic Features Suggestive of B/Myeloid Mixed-Phenotype Acute Leukemia (MPAL), Harboring Multiple <i>KMT2A</i> Gene Amplifications. [PDF]

Int J Mol Sci
Łączak J, Szarawarska M, Dudycz D, Bieńko K, Grzyb J, Skoczylas T, Blajer-Olszewska B, Kopacz A, Markiewicz M.   +8 more
europepmc   +1 more source

CHRONIC MYELOID LEUKEMIA

Nihon Naika Gakkai Zasshi, 1980
openaire   +3 more sources

Presenting a multi-marker response-adapted framework for venetoclax duration in acute myeloid leukemia. [PDF]

Ann Hematol
Adnan N.
europepmc   +1 more source